Inaugural issue of Cardiovascular Innovations and Applications journal launches

December 07, 2015

The new journal Cardiovascular Innovations and Applications (CVIA) has been launched with a Special Issue on Heart Failure. CVIA was founded on the occasion of the 25th anniversary of the Great Wall-International Congress of Cardiology (GW-ICC) in 2014 by Professor Dayi Hu, president of the GW-ICC and past president of the Chinese Society of Cardiology, who will serve as Founding Editor.

C. Richard Conti, MD, a past president of the American College of Cardiology and former Editor of Clinical Cardiology, servers as Editor-in-Chief of the new journal, which has published its first issue to coincide with the GW-ICC meeting in October 2015 in Beijing, China.

The GW-ICC is one of the largest congresses in the Asian-Pacific region and is the most comprehensive and influential academic conference on cardiology. Held as a regular annual conference since 1990, GW-ICC has provided a platform for continuing education in cardiovascular disease diagnosis, treatment, and technology training, through events that leverage the expertise of internationally renowned cardiologists and scholars from the United States, Europe and Asia.

The CVIA Special Issue on Heart Failure has been Guest Edited by Juan M. Aranda, Jr. of the University of Florida and brings together contributions from leading cardiologists from the United States, China and Europe.

Featured papers in this issue are:

A Clinician's Commentary on Heart Failure Treatment in the Future ( by C. Richard Conti. This paper considers the results of the latest heart failure trial entitled 'Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients with Chronic Heart Failure.'

Strategies to Reduce Heart Failure Hospitalizations and Readmission: How Low Can We Go? ( by Juan M. Aranda, Jr. This paper examines the strategies available to reduce heart failure readmission levels. It is estimated that more than one million heart failure hospitalizations occur each year and heart failure readmission rates continue to be about 25%. Strategies to reduce heart failure readmission are key to reducing hospitalization rates. This paper considers strategies available at three different stages of the treatment process: during hospitalization, before discharge and post-discharge. The interventions conducted by a multidisciplinary team adopting these strategies have great potential to reduce heart failure hospitalization rates.

Other papers in this issue include:

Editorial by the Founding Editor ( by Dayi Hu. This editorial notes the considerable rise in China-based cardiology papers in recent years, with China now the second largest source of cardiology papers in world research rankings. As such, it is now an opportune time to launch a new China-based cardiology journal to publish the best cardiology papers, with a wide range of contributors across China, the United States and Europe.

Congestive Heart Failure Clinics: How to Make Them Work in a Community-Based Hospital System ( by Joshua Larned, Mohamad Kabach, Leonardo Tamariz, and Kristine Raimondo. This paper concludes that Congestive Heart Failure (CHF) Clinics in community hospitals that use a rapid and frequent follow-up with CHF-trained teams effectively reduce hospitalization rates up to 1 year.

Heart Failure Issues and Management: A European Perspective ( by Alberto Dominguez-Rodriguez, Julia Gonzalez-Gonzalez, Carima Belleyo-Belkasem and Pedro Abreu-Gonzalez. This review provides a European perspective on management of heart failure.

Unusual Cardiomyopathies: Some May Be More Usual Than Previously Thought and Simply Underdiagnosed ( by Frank W Smart. This paper studies certain cardiomyopathies that have previously been regarded as very rare. These are being recognized with increasing frequency, because of improved imaging techniques and an increased understanding of the pathophysiologic mechanisms that result in these diseases.

Cardiac Sarcoidosis: Sorting Fact from Fiction in This Rare Cardiomyopathy ( by Indranee Rajapreyar and Elizabeth Langlois. This review details the current understanding of cardiac sarcoidosis and highlights diagnostic strategies and treatment with the aim of guiding the clinician to early identification of patients and implementation of appropriate management in this rare disease entity.

Epidemiological Study of Heart Failure in China ( by Yang Guo, Dong Zhao and Jing Liu: This review highlights important epidemiological studies of heart failure in China.

Noninvasive Hemodynamic Monitoring for Heart Failure: A New Era of Heart Failure Management ( by Gabriel A. Hernandez, Viviana Navas and Sandra Chaparro. This paper describes advances in implantable wireless technology that now allow frequent and direct measurement of intracardiac filling pressures, which can be monitored by health care providers to help tailor therapy to reduce filling pressures and hospital readmission rates.

The Evaluation of the Heart Failure Patient by Echocardiography: Time to go beyond the Ejection Fraction ( by Jacqueline Dawson Dowe, Juan Vilaro, Karen Hamilton, Anita Szady and Juan M. Aranda, Jr. This article reviews the role of the echocardiogram in the evaluation of the heart failure patient, without focusing on the left ventricle.

Pulmonary Arterial Hypertension and the Failing Ventricle: Getting It Right ( by Stacy A Mandras, Sylvia Oleck and Hector O. Ventura. This paper concludes that the discovery of new prognostic indicators, use of hybrid imaging for early detection of Right Ventricular Failure (RVF), and strategies to prevent the development of RVF will be important if outcomes in this patient population are to improve.

Cardiac Resynchronization Therapy in 2015: Lessons Learned ( by Siva Ketha and Fred M. Kusumoto. This paper reviews the pathobiology of cardiac dyssynchrony, the rationale for the use of CRT, the history and the state of the art of CRT, and guidelines and recommendations for CRT, while also focusing on the areas of controversy and potential future applications.

Continuous Flow Left Ventricular Assist Device Therapy: A Focused Review on Optimal Patient Selection and Long-Term Follow-up Using Echocardiography ( by Juan R. Vilaro, Anita Szady, Mustafa M. Ahmed, Jacqueline Dawson and Juan M. Aranda Jr. This paper provides a focused clinical review on the use of echocardiography in two main aspects of the evaluation of patients who are being considered for or are mechanically supported by Continuous Flow Left Ventricular Assist Devices (CF-LVADs): (a) optimal patient selection for CF-LVAD support and (b) follow-up assessment of optimal pump function.

Mechanical Circulatory Support for the Failing Heart: Which Device to Choose ( by Mustafa Ahmed and Rene Alvarez, Jr. This article reviews the literature and provides an algorithm for the treatment of cardiogenic shock.

CVIA publishes focused articles and original clinical research that explore novel developments in cardiovascular disease, effective control and rehabilitation in cardiovascular disease, and promote cardiovascular innovations and applications for the betterment of public health globally. The journal publishes basic research that has clinical applicability in order to promote timely communication of the latest insights relating to coronary artery disease, heart failure, hypertension, cardiac arrhythmia, and prevention of cardiovascular disease with a heavy emphasis on risk factor modification.

As part of its mandate to help bring interesting work and knowledge from around the world to a wider audience, CVIA will actively support authors through open access publishing and through waiving author fees in its first years. Also, publication support for authors whose first language is not English will be offered in areas such as manuscript development, English language editing and artwork assistance.
CVIA is available on the IngentaConnect platform and at Submissions may be made using Scholar One manuscripts at https:/ There are no author submission or article processing fees.

Cardiovascular Innovations and Applications

Related Heart Failure Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Machining the heart: New predictor for helping to beat chronic heart failure
Researchers from Kanazawa University have used machine learning to predict which classes of chronic heart failure patients are most likely to experience heart failure death, and which are most likely to develop an arrhythmic death or sudden cardiac death.

Heart attacks, heart failure, stroke: COVID-19's dangerous cardiovascular complications
A new guide from emergency medicine doctors details the potentially deadly cardiovascular complications COVID-19 can cause.

Autoimmunity-associated heart dilation tied to heart-failure risk in type 1 diabetes
In people with type 1 diabetes without known cardiovascular disease, the presence of autoantibodies against heart muscle proteins was associated with cardiac magnetic resonance (CMR) imaging evidence of increased volume of the left ventricle (the heart's main pumping chamber), increased muscle mass, and reduced pumping function (ejection fraction), features that are associated with higher risk of failure in the general population

Transcendental Meditation prevents abnormal enlargement of the heart, reduces chronic heart failure
A randomized controlled study recently published in the Hypertension issue of Ethnicity & Disease found the Transcendental Meditation (TM) technique helps prevent abnormal enlargement of the heart compared to health education (HE) controls.

Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure
A new study links the use of beta-blockers to heart failure hospitalizations among those with the common 'stiff heart' heart failure subtype.

Type 2 diabetes may affect heart structure and increase complications and death among heart failure patients of Asian ethnicity
The combination of heart failure and Type 2 diabetes can lead to structural changes in the heart, poorer quality of life and increased risk of death, according to a multi-country study in Asia.

Preventive drug therapy may increase right-sided heart failure risk in patients who receive heart devices
Patients treated preemptively with drugs to reduce the risk of right-sided heart failure after heart device implantation may experience the opposite effect and develop heart failure and post-operative bleeding more often than patients not receiving the drugs.

How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.

Novel heart pump shows superior outcomes in advanced heart failure
Severely ill patients with advanced heart failure who received a novel heart pump -- the HeartMate 3 left ventricular assist device (LVAD) -- suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

Read More: Heart Failure News and Heart Failure Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to